Mary Godwin Biography and Net Worth

Mary Godwin is the VP of Nautilus Biotechnology.

How old is Mary E. Godwin?: Godwin is currently 65 years old. There are 1 older executives and 6 younger executives at Nautilus Biotechnology. The oldest executive at Nautilus Biotechnology is Ms. Gwen E. Weld, Chief People Officer, who is 66 years old. Learn More on Mary E. Godwin's age.
How do I contact Mary E. Godwin?: The corporate mailing address for Godwin and other Nautilus Biotechnology executives is 51 ASTOR PLACE 10TH FLOOR, NEW YORK NY, 10003. Nautilus Biotechnology can also be reached via phone at 206-333-2001 and via email at [email protected]. Learn More on Mary E. Godwin's contact information.
Has Mary E. Godwin been buying or selling shares of Nautilus Biotechnology?: Mary E. Godwin has not been actively trading shares of Nautilus Biotechnology within the last three months. Learn More on Mary E. Godwin's trading history.
Who are Nautilus Biotechnology's active insiders?: Nautilus Biotechnology's insider roster includes Mary Godwin (VP), Matthew Mcilwain (Director), Anna Mowry (CFO), Matthew Murphy (General Counsel), Sujal Patel (CEO), Matthew Posard (Director), and Kentaro Suzuki (CMO). Learn More on Nautilus Biotechnology's active insiders.
Are insiders buying or selling shares of Nautilus Biotechnology?: In the last year, Nautilus Biotechnology insiders bought shares 8 times. They purchased a total of 277,500 shares worth more than $240,250.00. The most recent insider tranaction occured on March, 4th when CEO Sujal M Patel bought 25,000 shares worth more than $65,250.00. Insiders at Nautilus Biotechnology own 41.1% of the company. Learn More about insider trades at Nautilus Biotechnology.
Information on this page was last updated on 3/4/2026.

Mary E. Godwin Insider Trading History at Nautilus Biotechnology

Mary E. Godwin Buying and Selling Activity at Nautilus Biotechnology

Nautilus Biotechnology Company Overview

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Today's Range

Now: $3.95

$3.50

$3.98

50 Day Range

MA: $2.35

$1.83

$3.62

2 Week Range

Now: $3.95

$0.62

$3.98

Volume

1,131,571 shs

Average Volume

249,946 shs

Market Capitalization

$499.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44